Epizód összefoglalója
What if, instead of only studying why people get sick, we studied why some people stay healthy despite being genetically at risk of disease? In this episode of Beyond Bounds: Voices, host Mazar Masud, Senior Vice President, Corporate Affairs at M42, sits down with Dr. David J. Bearss, Ph.D., Co-Founder, CEO and President of Halia Therapeutics, to explore how genetic resilience could challenge some of the fundamental assumptions behind modern medicine. David shares the personal experiences that led him into science, his journey from laboratory researcher to biotech entrepreneur, and the moment a family carrying a genetic risk for Alzheimer’s changed the way he thought about disease. Instead of asking only what goes wrong?, David began asking a different question: what is protecting the people who don’t get sick? The conversation explores what that shift could mean for Alzheimer’s disease, precision medicine and the future of prevention, including how population-scale genomics in Abu Dhabi is enabling…
What if, instead of only studying why people get sick, we studied why some people stay healthy despite being genetically at risk of disease? In this episode of Beyond Bounds: Voices, host Mazar Masud, Senior Vice President, Corporate Affairs at M42, sits down with Dr. David J. Bearss, Ph.D., Co-Founder, CEO and President of Halia Therapeutics, to explore how genetic resilience could challenge some of the fundamental assumptions behind modern medicine. David shares the personal experiences that led him into science, his journey from laboratory researcher to biotech entrepreneur, and the moment a family carrying a genetic risk for Alzheimer’s changed the way he thought about disease. Instead of asking only what goes wrong?, David began asking a different question: what is protecting the people who don’t get sick? The conversation explores what that shift could mean for Alzheimer’s disease, precision medicine and the future of prevention, including how population-scale genomics in Abu Dhabi is enabling…
Epizódok
Dr. David J. Bearss | What If Medicine Has Been Asking the Wrong Question?
MeghallgatvaWhat if, instead of only studying why people get sick, we studied why some people stay healthy despite being genetically at risk of disease? In this episode of Beyond Bounds: Voices, host Mazar Masud, Senior Vice President, Corporate Affairs at M42, sits down with Dr. David J. Bearss, Ph.D., Co-Founder, CEO and President of Halia Therapeutics, to explore how genetic resilience could challenge some of the fundamental assumptions behind modern medicine. David shares the personal experiences that led him into science, his journey from laboratory researcher to biotech entrepreneur, and the moment a family carrying a genetic risk for Alzheimer’s changed the way he thought about disease. Instead of asking only what goes wrong?, David began asking a different question: what is protecting the people who don’t get sick? The conversation explores what that shift could mean for Alzheimer’s disease, precision medicine and the future of prevention, including how population-scale genomics in Abu Dhabi is enabling…